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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A321The current study aimed to investigate whether hyperactivation of the
RAS inﬂuences OA using forced-running mice models.
Methods: C57/BL6 mice and Tsukuba hypertensive mice (THM) were
forced to run (25m/min, 30 min/day, 5days/week) (n¼10). OA histo-
pathology was analyzed using the OARSI score at 0, 2, 4, 6, and 8 weeks.
Expression of type II collagen, type X collagen, MMP-13, ADAM-TS5 and
some RAS components were also analyzed.
Results: The OARSI scores of the lateral femoral condyles were sig-
niﬁcantly higher in the THM than in the C57BL/6 mice at 4, 6 and 8
weeks. However, in medial femoral condyles, there were not signiﬁcant
differencesbetween C57/BL6mice and THM. At 8 weeks, type II collagen
was stained in a lower number of chondrocytes in the THM than C57/
BL6 mice. The expression of type X collagen, MMP-13 and ADAM-TS5
was conﬁrmed in the THM, but not in the C57/BL6 mice. In the THM, we
compared the expression of angiotensin II type 1 receptor (AT1R) and
AT2R at each week. At 0 weeks, we could not conﬁrm the expression of
AT1R and AT2R. However, we conﬁrmed the expression of AT1R and
AT2R at 2, 4, 6, 8 weeks.
Conclusions:We conﬁrmed that the hyper activation of RAS induces OA
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Purpose: Interleukin-17 (IL-17) is an important factor in the patho-
genesis of autoimmune diseases and allergy, and IL-17 antagonists are
currently evaluated in randomized trials with encouraging results. In
OA IL-17 contributes to cartilage breakdown and synovial infiltration by
inducing the release of chemokines by chondrocytes and synovial
fibroblasts independent of the IL-1 and TNF-a pathway. It also affects
cartilage matrix turnover, induces angiogenesis in articular tissue, and
ampliﬁes joint inﬂammation. However, IL-17 is only infrequently
detected in OA and clinical studies are sparse.
We aimed at evaluating the relation between absence or presence of IL-
17 in synovial ﬂuid (SF) of patients with endstage knee and hip OA and
(1) other (adipo-)cytokine SF concentrations, and (2) clinical and
radiographic disease parameters.
Methods: Cross-sectional study including patients prior to total hip
(THA) and knee arthroplasty (TKA) operated upon for primary OA at a
large tertiary hospital between January and December 2010. The
morning of surgery concentrations of IL-17, IL-6, leptin, visfatin, adi-
ponectin, resistin, MCP-1, MCP-3 and NGF were sampled from synovial
ﬂuid and assessed using ELISA kits. Baseline characteristics recorded
preoperatively included age, sex, BMI, co-morbidities, pain and function
(WOMAC), and radiographic analyses (OA features, K&L grade, minimal
JSW).
Results: 152 patients were included, 68 prior to THA and 84 to TKA.
Mean age was 73 (±9) years, 64% were women. In 14 patients (9.2%) IL-
17was present in the SF (median concentration 7.9 pg/ml, IQR 1.6; 20.6).
These patients had signiﬁcantly higher median SF concentrations of IL-
6, leptin, resistin, MCP-3 and b-NGF, and a tendency to be female,
younger, and obese class II, as compared to those without IL-17.
Radiographic analyses revealed a signiﬁcantly reduced minJSW
together with a lower proportion of sclerosis and osteophytes in the
presence of IL-17 in SF. No differences were found with respect to pain,
function and comorbidities. There was a moderate correlation between
Il-17 concentrations in SF and serum (r¼0.482).
Conclusions: The presence of IL-17 in SF of patients with primary end
stage OA was associated with high levels of several other proin-
ﬂammatory adipokines, cytokines and chemokines, and with a different
radiographic OA feature pattern. Moreover, patients tended to be
younger, more oftenwomen and obese class II. Our results may indicate
a different OA phenotype with a potential for a new treatment option.511
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Purpose: To determine the associations between knee pain severity and
progression versus MRI features, including cartilage, osteophytes, bone
marrow lesions (BML), subchondral sclerosis, meniscus, subchondral
cysts and effusion, in a population-based cohort with knee pain.
Methods: Baseline, mean 3.3- and mean 7.5-year follow-up MRI
assessments of the study (painful) knee were performed for 122 sub-
jects with baseline knee pain, age 40-79 at baseline, sample-weighted
for population (with knee pain) representativeness in Vancouver, BC
(the Vancouver Longitudinal Study of Early Knee OA). MRIs were
acquired on a 1.5Tmagnet at a single centre using a transmitter-receiver
extremity knee coil, and 3 planes double-echo weighted sequences
with and without fat suppressionwere obtained. MRIs were scored by a
single experienced reader for cartilage (0¼normal to 4¼full thickness
defect; 0/1 collapsed to 1¼only signal change), BML (0¼absent to
3¼severe), subchondral sclerosis (0¼absent to 3¼severe) and sub-
chondral cyst (0¼absent to 3¼severe) in 6 regions: lateral and medial
femur, lateral and medial tibia, patella and trochlear groove. Meniscus
(0¼normal to 3¼maceration/resection) was also scored in 6 regions:
lateral anterior, lateral body, lateral posterior, medial anterior, medial
body and medial posterior. Osteophytes (0¼absent to 3¼large) were
scored in 8 regions: lateral and medial femur, lateral and medial tibia,
and lateral, medial, superior and inferior patella. For each feature,
region scores were added up and the sum divided by the number of
regions. Effusion (0¼absent to 3¼severe) was scored for the overall
knee and included as an indicator for >¼2. Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) knee pain scale
(normalized 0-100; higher numbers worse) was administered at each
time point.
Cross-sectional models of pain were ﬁt on 3 time points simultaneously
(N¼366), using generalized estimating equations (GEE) to account for
correlated data. Longitudinal (change) models of delta pain, and indi-
cators for 10þ points increase in pain, and 20þ points increase in pain
were ﬁt on both 2-cycle changes simultaneously (cycles 1-2 and 2-3;
N¼244), using GEE for binary or linear regression. Models for each
feature were adjusted for age, sex and BMI (and follow-up time for
longitudinal models).
Results: 55.7% of the weighted sample was female. At baseline, mean
BMI was 26.1 and mean age was 55.5. Mean divided score sums at
baseline were 1.74 for cartilage, 0.93 for osteophytes, 0.27 for BML, 0.08
for subchondral sclerosis, 0.48 for meniscus and 0.06 for subchondral
cysts. Average normalized WOMAC pain at baseline was 19.1. 29.6% had
baseline effusion >¼2. Spearman rank correlations among the seven
MRI features were all signiﬁcantly >0, ranging from 0.21 (meniscus vs.
subchondral cyst) to 0.68 (osteophyte vs. cartilage).
In cross-sectional regression models, osteophytes were signiﬁcantly
associated with pain (coefﬁcient¼7.17; 95% CI¼3.19, 11.15), as was
subchondral sclerosis (11.03; 0.68, 21.39). In longitudinal linear models
of delta pain score, cartilage and osteophytes were signiﬁcantly asso-
ciated with pain change, respectively 4.31 (0.67, 7.95) and 4.51 (0.53,
8.49). In longitudinal binary models of delta pain score >¼10, osteo-
phytes (OR¼3.20; 1.36, 7.55), subchondral sclerosis (OR¼5.69; 1.06,
30.44), meniscus (OR¼1.68; 1.08, 2.61) and effusion >¼2 (OR¼2.25;
1.07, 4.71) were signiﬁcantly associated with pain increase. Finally, in
binary models of delta pain score >¼20, cartilage and osteophytes were
signiﬁcantly associated with pain increase, respectively OR¼2.42 (1.24,
4.74) and 3.79 (1.41, 10.20). No associations were observed between
pain severity or pain progression and BML or subchondral cysts, after
adjusting for age, sex and BMI.
Conclusions: In this population-based cohort with 7-year follow-up we
found a positive association between knee pain severity and both
